XEL
67
2
MPC
36
3
TRIP
60
3
KSS
30
4
VZ
55
3
SYK
53
3
VIX
36
-7
APH
83
2
SBUX
41
4
MUR
34
3
EXPD
32
3
JWN
57
4
PYPL
66
4
STX
69
3
GOOG
75
6
WEC
73
-2
CA
46
-3
CME
59
3
EQR
47
3
CSCO
60
4
XEL
67
2
MPC
36
3
TRIP
60
3
KSS
30
4
VZ
55
3
SYK
53
3
VIX
36
-7
APH
83
2
SBUX
41
4
MUR
34
3
EXPD
32
3
JWN
57
4
PYPL
66
4
STX
69
3
GOOG
75
6
WEC
73
-2
CA
46
-3
CME
59
3
EQR
47
3
CSCO
60
4
Financhill
Back

Ironwood Pharmaceuticals 10K Form

Sell
26

IRWD
Ironwood Pharmaceuticals

Last Price:
$0.93
Seasonality Move:
1.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-09 10Q IRWD/Ironwood Pharmaceuticals Quarterly
2023-11-09 10Q IRWD/Ironwood Pharmaceuticals Quarterly
2023-08-09 10Q IRWD/Ironwood Pharmaceuticals Quarterly
2023-05-04 10Q IRWD/Ironwood Pharmaceuticals Quarterly
2022-11-03 10Q IRWD/Ironwood Pharmaceuticals Quarterly
2022-08-04 10Q IRWD/Ironwood Pharmaceuticals Quarterly

Receive IRWD News And Ratings

See the #1 stock for the next 7 days that we like better than IRWD

IRWD Financial Statistics

Sales & Book Value

Annual Sales: $351.4M
Cash Flow: $9.9M
Price / Cash Flow: 1.44
Annual Sales: $-1.88
Price / Book: 0

Profitability

EPS (TTM): 0.00000
Net Income (TTM): $1.8M
Gross Margin: $410.6M
Return on Equity: 0%
Return on Assets: 0.44%

Ironwood Pharmaceuticals Earnings Forecast

Key Ironwood Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 16 years for IRWD is 100.00%.
  • The Selling, General & Administrative Expenses for IRWD have been equal to 41.06% of Gross Profit Margin.
  • The Research & Development expenses have been 31.71% of Revenue.
  • The Interest Expense is 3,753.86% of Operating Income.
  • The Net Earning history of IRWD is 0.25% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 8 years.

Ironwood Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IRWD
CUSIP: 46333X
Website: ironwoodpharma.com

Debt

Debt-to-Equity Ratio: -1.94
Current Ratio: 4.66
Quick Ratio: 4.35

Price-to-Earnings

Trailing P/E Ratio: 93.23
Forward P/E Ratio: 2.11

IRWD Technical Analysis vs Fundamental Analysis

Sell
26
Ironwood Pharmaceuticals (IRWD) is a Sell

Is Ironwood Pharmaceuticals a Buy or a Sell?